VITAMIN K-DEPENDENT COAGULATION DEFECT

Clinical trials for VITAMIN K-DEPENDENT COAGULATION DEFECT explained in plain language.

Never miss a new study

Get alerted when new VITAMIN K-DEPENDENT COAGULATION DEFECT trials appear

Sign up with your email to follow new studies for VITAMIN K-DEPENDENT COAGULATION DEFECT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Head-to-Head safety check: which Clot-Reversal drug is safer before emergency surgery?

Disease control Recruiting now

This observational study compares the safety of two drugs, BALFAXAR and KCENTRA, used to reverse the effects of vitamin K antagonist blood thinners (like warfarin) in adults who need urgent surgery or an invasive procedure. The main goal is to see how often blood clots (thromboem…

Matched conditions: VITAMIN K-DEPENDENT COAGULATION DEFECT

Sponsor: Octapharma • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC

VITAMIN K-DEPENDENT COAGULATION DEFECT

Get alerted when new VITAMIN K-DEPENDENT COAGULATION DEFECT trials appear

Head-to-Head safety check: which Clot-Reversal drug is safer before emergency surgery?